Costa Rica vs Moldova: Cause of death, by non-communicable diseases, female
Costa Rica
74.2%
in 2021
Moldova
73.9%
in 2021
Costa Rica rank
68th
Moldova rank
70th
Cause of death, by non-communicable diseases, female over time
- Costa Rica
- Moldova
How they compare
Costa Rica currently reports 74.2% against 73.9% in Moldova, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Moldova ahead.
Costa Rica ranks 68th and Moldova ranks 70th of 185 countries.
Across the 3 decades both report, Costa Rica averaged higher in 1 and Moldova in 2.
Head to head by decade
| Decade | Costa Rica | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 83.8% | 93.4% | 9.6% | Moldova |
| 2010s | 87.6% | 94.1% | 6.5% | Moldova |
| 2020s | 78.9% | 78.6% | 0.4% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Costa Rica or Moldova?
- Costa Rica, at 74.2% against 73.9% in Moldova as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Costa Rica and Moldova?
- 0.3%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Moldova?
- 6 years are reported by both, from 2000 to 2021.
- How do Costa Rica and Moldova rank globally for cause of death, by non-communicable diseases, female?
- Costa Rica ranks 68th and Moldova ranks 70th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.